"10.1371_journal.pone.0013188","plos one","2010-10-06T00:00:00Z","Nicholas Funderburg; Magdalena Kalinowska; James Eason; James Goodrich; Jayvant Heera; Howard Mayer; Natasa Rajicic; Hernan Valdez; Michael M Lederman","Case Western Reserve University, Cleveland, Ohio, United States of America; ViiV Healthcare, Research Triangle Park, North Carolina, United States of America; Pfizer Global Research and Development, New London, Connecticut, United States of America; EMD Serono, Rockland, Massachusetts, United States of America; Pfizer Inc, New York, New York, United States of America","Analyzed the data: NF MK JE JG JH HM NR HV ML. Wrote the paper: NF MK JE JG JH HM NR HV ML.","Authors H. Valdez, J. Goodrich, J. Heera, and N. Rajicic are all Pfizer and or ViiV Healthcare employees. Author M. Letterman is the recipient of research grant support and has also served as a consultant to Pfizer. Authors N. Case, M. Kalinowska, J. Eason, and H. Mayer have no competing interest. Maraviroc is a product of Pfizer. The responsibilities preformed do not alter the authors' adherence to the PLoS ONE policies on sharing data and materials and has not influenced the final manuscript in any way.","2010","10","Nicholas Funderburg","NF",9,FALSE,NA,NA,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
